The poor early surgical prognosis of some patients with nonsmall cell lung cancer is related to the Rac1 upregulation, which may be related to the fact that the high expression of Rac1 in nonsmall cell lung cancer tumor stem cells can enhance the malignant behavior of tumor cells [22]. The gene discussed is RAC1; the disease is neoplasm.